235 related articles for article (PubMed ID: 7629244)
21. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
22. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves' disease.
Kasuga Y; Sugenoya A; Kobayashi S; Shimizu T; Onuma H; Shingu K; Asanuma K; Hama Y; Iida F
J Am Coll Surg; 1994 Jun; 178(6):589-94. PubMed ID: 7910771
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
24. Complex investigation of Graves'-Basedow disease: case report.
Luca IC; Bene MC; Cotuţiu C
Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):202-4. PubMed ID: 10756799
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
26. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
27. Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.
Williams RC; Marshall NJ; Kilpatrick K; Montano J; Brickell PM; Goodall M; Ealey PA; Shine B; Weetman AP; Craig RK
J Clin Invest; 1988 Oct; 82(4):1306-12. PubMed ID: 2902107
[TBL] [Abstract][Full Text] [Related]
28. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
29. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.
Komiya I; Yamada T; Sato A; Kouki T; Nishimori T; Takasu N
J Clin Endocrinol Metab; 2001 Aug; 86(8):3540-4. PubMed ID: 11502776
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of surface phenotype study of intrathyroidal lymphocytes obtained by fine needle aspiration cytology in autoimmune thyroid disease and malignant lymphoma of the thyroid.
Fujikawa M; Okamura K; Sato K; Mizokami T; Tanabe S; Ikenoue H; Okamura S; Ohta M; Fujishima M
Clin Endocrinol (Oxf); 1998 Aug; 49(2):191-6. PubMed ID: 9828906
[TBL] [Abstract][Full Text] [Related]
31. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
33. Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.
Marcocci C; Chiovato L; Mariotti S; Pinchera A
J Endocrinol Invest; 1982; 5(1):13-9. PubMed ID: 6896520
[TBL] [Abstract][Full Text] [Related]
34. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
[TBL] [Abstract][Full Text] [Related]
35. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
36. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
[TBL] [Abstract][Full Text] [Related]
37. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
[TBL] [Abstract][Full Text] [Related]
38. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M
BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286
[TBL] [Abstract][Full Text] [Related]
39. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
40. Successful production of intrathyroidal human T cell hybridomas: evidence for intact helper T cell function in Graves' disease.
Martin A; Schwartz AE; Friedman EW; Davies TF
J Clin Endocrinol Metab; 1989 Dec; 69(6):1104-8. PubMed ID: 2531154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
